-+ 0.00%
-+ 0.00%
-+ 0.00%

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Benzinga·08/07/2025 12:07:31
Listen to the news

Gainers

  • Outset Medical (NASDAQ:OM) stock increased by 26.8% to $16.7 during Thursday's pre-market session. The company's market cap stands at $233.4 million. As per the news, the Q2 earnings report came out yesterday.
  • Aveanna Healthcare Hldgs (NASDAQ:AVAH) shares increased by 22.09% to $4.75. The market value of their outstanding shares is at $802.4 million. As per the news, the Q2 earnings report came out today.
  • Ironwood Pharmaceuticals (NASDAQ:IRWD) stock rose 21.72% to $0.98. The company's market cap stands at $130.2 million. As per the press release, Q2 earnings came out today.
  • Guardant Health (NASDAQ:GH) stock moved upwards by 20.49% to $53.73. The market value of their outstanding shares is at $5.5 billion.
  • Niagen Bioscience (NASDAQ:NAGE) shares moved upwards by 15.95% to $10.9. The market value of their outstanding shares is at $740.4 million. The company's, Q2 earnings came out yesterday.
  • Lantern Pharma (NASDAQ:LTRN) stock increased by 14.2% to $5.87. The market value of their outstanding shares is at $55.4 million.

Losers

  • Sana Biotechnology (NASDAQ:SANA) stock declined by 23.8% to $3.24 during Thursday's pre-market session. The market value of their outstanding shares is at $958.6 million.
  • Tandem Diabetes Care (NASDAQ:TNDM) shares decreased by 20.09% to $11.5. The market value of their outstanding shares is at $956.5 million. As per the news, the Q2 earnings report came out yesterday.
  • Biote (NASDAQ:BTMD) shares decreased by 18.4% to $3.15. The company's market cap stands at $121.5 million. As per the press release, Q2 earnings came out yesterday.
  • Exact Sciences (NASDAQ:EXAS) stock decreased by 16.65% to $39.1. The market value of their outstanding shares is at $8.8 billion. The company's, Q2 earnings came out yesterday.
  • Eledon Pharmaceuticals (NASDAQ:ELDN) shares fell 14.54% to $2.94. The company's market cap stands at $205.9 million.
  • ADMA Biologics (NASDAQ:ADMA) shares declined by 13.17% to $16.1. The market value of their outstanding shares is at $4.4 billion. As per the press release, Q2 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.